HRSA Threatens To Fine Drug Makers Over 340B Restrictions

By John Wilkerson / May 17, 2021 at 7:28 PM

The Health Resources and Services Administration threatened to fine drug makers that continue to restrict discounts to hospitals and clinics that dispense 340B drugs through multiple contract pharmacies, and HRSA said drug makers must refund hospitals.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.